| Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia C Hernández-Gómez, VM Blanco, G Motoa, A Correa, M Vallejo, ... Biomédica 34, 91-100, 2014 | 132 | 2014 |
| Infecciones del tracto urinario bajo en adultos y embarazadas: consenso para el manejo empírico E Martínez, J Osorio, J Delgado, GE Esparza, G Motoa, VM Blanco, ... Infectio 17 (3), 122-135, 2013 | 130 | 2013 |
| An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the … LJ Rojas, GM Weinstock, E De La Cadena, L Diaz, R Rios, BM Hanson, ... The Journal of infectious diseases 217 (1), 82-92, 2018 | 97 | 2018 |
| Genomic and Molecular Characterization of Clinical Isolates of Enterobacteriaceae Harboring mcr-1 in Colombia, 2002 to 2016 SY Saavedra, L Diaz, M Wiesner, A Correa, SA Arévalo, J Reyes, ... Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 00841-17, 2017 | 75 | 2017 |
| First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases A Correa, MC Montealegre, MF Mojica, JJ Maya, LJ Rojas, ... Antimicrobial agents and chemotherapy 56 (10), 5422-5423, 2012 | 69 | 2012 |
| Microbiological and Clinical Aspects of Raoultella spp. TM Appel, N Quijano-Martínez, E De La Cadena, MF Mojica, MV Villegas Frontiers in public health 9, 686789, 2021 | 66 | 2021 |
| Emergence of Klebsiella pneumoniae coharboring KPC and VIM carbapenemases in Colombia LJ Rojas, MF Mojica, VM Blanco, A Correa, MC Montealegre, ... Antimicrobial agents and chemotherapy 57 (2), 1101-1102, 2013 | 60 | 2013 |
| Dynamics of blaKPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity AM Rada, E De La Cadena, C Agudelo, C Capataz, N Orozco, C Pallares, ... Antimicrobial agents and chemotherapy 64 (12), 10.1128/aac. 01743-20, 2020 | 56 | 2020 |
| Impact of antimicrobial stewardship programs on antibiotic consumption and antimicrobial resistance in four Colombian healthcare institutions C Pallares, C Hernández-Gómez, TM Appel, K Escandón, S Reyes, ... BMC infectious diseases 22 (1), 420, 2022 | 43 | 2022 |
| Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa MF Mojica, E De La Cadena, C Hernández-Gómez, A Correa, TM Appel, ... Journal of Global Antimicrobial Resistance 21, 391-395, 2020 | 40 | 2020 |
| Genetic Diversity of Multidrug-Resistant Pseudomonas aeruginosa Isolates Carrying blaVIM–2 and blaKPC–2 Genes That Spread on Different Genetic … AM Rada, E De La Cadena, CA Agudelo, C Pallares, E Restrepo, ... Frontiers in microbiology 12, 663020, 2021 | 36 | 2021 |
| Initial Assessment of the Molecular Epidemiology of blaNDM-1 in Colombia LJ Rojas, MS Wright, E De La Cadena, G Motoa, KM Hujer, MV Villegas, ... Antimicrobial agents and chemotherapy 60 (7), 4346-4350, 2016 | 35 | 2016 |
| Novel VIM metallo-β-lactamase variant, VIM-24, from a Klebsiella pneumoniae isolate from Colombia MC Montealegre, A Correa, DF Briceno, NC Rosas, E De La Cadena, ... Antimicrobial agents and chemotherapy 55 (5), 2428-2430, 2011 | 35 | 2011 |
| In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC‐ and Non‐AmpC‐Mediated Pathways E Skoglund, H Abodakpi, R Rios, L Diaz, E De La Cadena, AQ Dinh, ... Case Reports in Infectious Diseases 2018 (1), 9095203, 2018 | 31 | 2018 |
| Antimicrobial stewardship programs in seven Latin American countries: facing the challenges CJ Pallares, J Porras, E De La Cadena, JC García-Betancur, ... BMC Infectious Diseases 23 (1), 463, 2023 | 29 | 2023 |
| Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals MF Mojica, E De La Cadena, JC García-Betancur, J Porras, ... Msphere 8 (2), e00651-22, 2023 | 27 | 2023 |
| Actualización sobre la resistencia antimicrobiana en instituciones de salud de nivel III y IV en Colombia entre enero del 2018 y diciembre del 2021 E De La Cadena, CJ Pallares, JC García-Betancur, JA Porras, ... Biomédica 43 (4), 457-473, 2023 | 25 | 2023 |
| Estrategias para la implementación y reporte de los puntos de corte CLSI vigentes y pruebas fenotípicas confirmatorias para BLEE y carbapenemasas en bacilos Gram negativos en … G Esparza, B Ariza, AM Bedoya, I Bustos, CR Castañeda-Ramirez, ... Infectio 17 (2), 80-89, 2013 | 23 | 2013 |
| Evolution of antimicrobial resistance in Gram negative bacilli from intensive care units in Colombia C Hernandez-Gomez, VM Blanco, G Motoa, A Correa, M Vallejo, ... Biomedica 34, 91-100, 2014 | 20 | 2014 |
| In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries VMV Appel TM, Mojica MF, De La Cadena E, Pallares CJ, Radice MA, Castañeda ... Antibiotics 9 (2), 62, 2020 | 18 | 2020 |
